A new lens on Guangxi
BEIJING,Nov. 4,2024-- A report from China Daily: "When one thinks of Guangxi,Guilin typically springs to mind. However,this time,we are exploring a broader array of cities - some lesser-known yet
BEIJING,Nov. 4,2024-- A report from China Daily: "When one thinks of Guangxi,Guilin typically springs to mind. However,this time,we are exploring a broader array of cities - some lesser-known yet
DALIAN,China,Nov. 4,2024-- CBAK Energy Technology,Inc. (NASDAQ: CBAT) ("CBAK Energy",or the "Company"),a leading lithium-ion battery manufacturer and electric energy solution provi
CHICAGO,Nov. 4,2024-- AtFABTECH 2024 in Orlando,October 15-17,Tailift showcased its latest advancements in intelligent manufacturing,attracting extensive industry attention. Known for its technical in
WUHAN,China,Nov. 4,2024-- China Automotive Systems,Inc. (Nasdaq: CAAS) ("CAAS" or the "Company"), a leading power steering components and systems supplier in China,today announced
SINGAPORE,Nov. 5,2024-- MADLY Bespoke Jeweller,Singapore\'s foremost jewellery design house specialising in coloured gemstones,proudly marks its 10th anniversary this November. Celebrating a decade o
HHAn-Wuhan Polar Ocean Park Takes Center Stage with Successful Flag Handover in advance of 2027 IAC WUHAN,China,Nov. 3,2024-- On November 1,2024,the International Aquarium Congress (IAC),often referre
BANGKOK,Nov. 4,2024-- Mintel,the world\'s leading market intelligence agency,is set to present exclusive insights at in-cosmetics Asia 2024 with sessions on the 2025 Global Beauty and Personal Care T
HANOI,Vietnam,Oct. 31,2024-- As part of Sustainability Management,MNFV- a member of Japan\'s leading dairy and nutrition companyMorinaga Milk Group- practices human rights and diversity considerations
HONG KONG,Oct. 31,2024-- On October 17,2024,the 2024CAHK STAR Award Ceremony concluded successfully in Hong Kong. China Telecom Global was honored with the "Best AI Application Award."
BOSTON,Oct. 31,2024-- In a remarkable development for cancer research,patients with advanced-stage cancer have benefited fromSUPLEXA,a personalized treatment that trains the patient\'s own immune cel